Related references
Note: Only part of the references are listed.Testosterone for the aging male; current evidence and recommended practice
Hugh Jones
Clinical Interventions in Aging (2016)
Testosterone Therapy in Men With Untreated Prostate Cancer
Abraham Morgentaler et al.
JOURNAL OF UROLOGY (2011)
Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging
Phillip M. Pierorazio et al.
BJU INTERNATIONAL (2010)
Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls
Hermann M. Behre et al.
CLINICAL ENDOCRINOLOGY (2010)
Low serum testosterone and increased mortality in men with coronary heart disease
Chris J. Malkin et al.
HEART (2010)
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
Shalender Bhasin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Intermittent androgen suppression for prostate cancer
Nicholas C. Buchan et al.
NATURE REVIEWS UROLOGY (2010)
Adverse Events Associated with Testosterone Administration
Shehzad Basaria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men
Frederick C. W. Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth
Abraham Morgentaler et al.
EUROPEAN UROLOGY (2009)
Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review
R. Shabsigh et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2009)
ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males
C. Wang et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2009)
Testosterone Replacement Therapy Following Radical Prostatectomy
Mohit Khera et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients?
T. Imamoto et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2009)
Absence of Relationship Between Steroid Hormone Levels and Prostate Cancer Tumor Grade
David J. Sher et al.
UROLOGY (2009)
Testosterone therapy and prostate carcinoma
Ernani Luis Rhoden et al.
Current Urology Reports (2009)
Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes
R. D. Stanworth et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Low serum testosterone and mortality in older men
Gail A. Laughlin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: The European Male Aging Study
Frederick C. W. Wu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Androgen replacement in men undergoing treatment for prostate cancer
Ernani Luis Rhoden et al.
JOURNAL OF SEXUAL MEDICINE (2008)
Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies
Andrew W. Roddam et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Diagnosing and treating testosterone deficiency in different parts of the world. Results from global market research
Louis J. Gooren et al.
AGING MALE (2007)
Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice
Whitney Banach-Petrosky et al.
CANCER RESEARCH (2007)
Characterization of androgen-regulated expression of CYP3A5 in human prostate
Anne-Mari Moilanen et al.
CARCINOGENESIS (2007)
Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer
Jiri Heracek et al.
STEROIDS (2007)
Locally advanced prostate cancer - Biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy
Nicholas Bruchovsky et al.
CANCER (2007)
Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy
Michael F. Sarosdy
CANCER (2007)
Prostate cancer risk in testosterone-treated men
Jean-Pierre Raynaud
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism - A randomized controlled trial
Leonard S. Marks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Association of specific symptoms and metabolic risks with serum testosterone in older men
Michael Zitzmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Testosterone and prostate cancer: An historical perspective on a modern myth
Abraham Morgentaler
EUROPEAN UROLOGY (2006)
Growth inhibitory concentrations of androgens up-regulate insulin-like growth factor binding protein-3 expression via an androgen response element in LNCaP human prostate cancer cells
Lihong Peng et al.
ENDOCRINOLOGY (2006)
Low serum testosterone and mortality in male veterans
Molly M. Shores et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Testosterone replacement therapy and the risk of prostate cancer. Is there a link?
A. Barqawi et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2006)
Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men
T Münzer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
DC Gould et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2006)
Prostate-specific antigen: Update 2006
SJ Freedland et al.
UROLOGY (2006)
Circulating steroid hormones and the risk of prostate cancer
G Severi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials
OM Calof et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2005)
Prostate cancer in men using testosterone supplementation
FD Gaylis et al.
JOURNAL OF UROLOGY (2005)
Testosterone as a predictor of pathological stage in clinically localized prostate cancer
G Isom-Batz et al.
JOURNAL OF UROLOGY (2005)
Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy
T Imamoto et al.
EUROPEAN UROLOGY (2005)
Testosterone replacement therapy after primary treatment for prostate cancer
PK Agarwal et al.
JOURNAL OF UROLOGY (2005)
Medical progress - Risks of testosterone-replacement therapy and recommendations for monitoring
EL Rhoden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men
JM Kaufman et al.
JOURNAL OF UROLOGY (2004)
Prevalence and incidence of androgen deficiency in middle-aged and older men: Estimates from the Massachusetts Male Aging Study
AB Araujo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Intramuscular testosterone undecanoate:: Pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism
M Schubert et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men
C Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Oestrogens and prostate cancer
GP Risbridger et al.
ENDOCRINE-RELATED CANCER (2003)
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy
JC Massengill et al.
JOURNAL OF UROLOGY (2003)
Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: Results of 1 year of treatment in men with prostatic intraepithelial neoplasia
EL Rhoden et al.
JOURNAL OF UROLOGY (2003)
Reduced risk of prostate cancer among patients with diabetes mellitus
E Weiderpass et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels
GK Lefkowitz et al.
JOURNAL OF UROLOGY (2002)
Is the flare phenomenon clinically significant?
GJ Bubley
UROLOGY (2001)
The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: Initial results of endocrinological and biochemical efficacies in patients with prostate cancer
K Tomera et al.
JOURNAL OF UROLOGY (2001)
Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels
AM Kenny et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2001)
Leptin is associated with increased prostate cancer risk:: A nested case-referent study
P Stattin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Longitudinal effects of aging on serum total and free testosterone levels in healthy men
SM Harman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Hormones and prostate cancer: What's next?
AW Hsing
EPIDEMIOLOGIC REVIEWS (2001)
Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men
C Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Effects of testosterone replacement in hypogonadal men
PJ Snyder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
